<p>Pharming Group NV (OTCMKTS:PHGUF - 获取免费报告) 的股价在周五市场开盘前出现下跌。该股票之前收于 1.70 美元，但开盘时为 1.51 美元。Pharming Group 的股票最后交易价格为 1.51 美元，成交量为 1,000 股。</p>
<p>获取 <strong>Pharming Group</strong> 的提醒：</p>
<h2>Pharming Group 股票表现</h2>
<p>该公司的 50 日简单移动平均线为 1.78 美元，200 日简单移动平均线为 1.60 美元。该公司的市值为 10.1 亿美元，市盈率为 151.15，贝塔值为 0.42。公司当前比率为 3.16，速动比率为 2.39，债务与股本比率为 0.46。</p>
<h2>关于 Pharming Group</h2>
<p>(获取免费报告)</p>
<p>Pharming Group NV 是一家总部位于荷兰的生物制药公司，专注于为罕见疾病开发和商业化蛋白质替代疗法。公司成立于 1988 年，总部位于莱顿，利用转基因技术生产重组蛋白，其旗舰产品 RUCONEST（重组 C1 酯酶抑制剂）用于治疗急性遗传性血管性水肿（HAE）发作。RUCONEST 已在美国、欧洲及其他多个地区获得批准并通过与领先的专业制药公司合作进行市场推广。</p>
<p>除了 RUCONEST，Pharming 还保持着多样化的产品线，针对罕见和超罕见疾病的未满足需求。</p>
<h2>了解更多</h2>
<ul>
<li>五只我们更看好的股票，胜过 Pharming Group</li>
<li>BNZI 在 Zacks 买入评级中脱颖而出。盈利势头和分析师升级一致</li>
<li>你的名字尚未在我们的保护名单上</li>
<li>银银支付 20% 股息。此外，股价上涨 68%</li>
<li>用这 4 个简单步骤 “防止美联储影响” 你的银行账户</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Pharming Group 吗？</h2>
<p>在考虑 Pharming Group 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Pharming Group 并不在名单上。</p>
<p>虽然 Pharming Group 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

标普医疗保健服务 ETF - SPDR

美国制药 ETF - iShares

生物科技 ETF - VanEck Vectors

<p>Pharming Group（OTCMKTS:PHGUF）在周五市场开盘前，股价从 1.70 美元跳空下跌至 1.51 美元，交易量为 1,000 股。这家公司是一家总部位于荷兰的生物制药公司，专注于罕见疾病的蛋白质替代疗法，特别是用于遗传性血管水肿的 RUCONEST。Pharming 的市值为 10.1 亿美元，市盈率为 151.15，流动比率为 3.16。分析师目前对该股票的评级为持有，但建议其他股票可能是更好的投资选择</p>

<p>Pharming Group NV (OTCMKTS:PHGUF - Get Free Report)'s share price gapped down before the market opened on Friday . The stock had previously closed at $1.70, but opened at $1.51. Pharming Group shares last traded at $1.51, with a volume of 1,000 shares changing hands.</p>
<div class="lb-trans"><p>Pharming Group NV (OTCMKTS:PHGUF - 获取免费报告) 的股价在周五市场开盘前出现下跌。该股票之前收于 1.70 美元，但开盘时为 1.51 美元。Pharming Group 的股票最后交易价格为 1.51 美元，成交量为 1,000 股。</p>
</div><p>Get <strong>Pharming Group</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Pharming Group</strong> 的提醒：</p>
</div><h2>Pharming Group Stock Performance</h2>
<div class="lb-trans"><h2>Pharming Group 股票表现</h2>
</div><p>The business's 50 day simple moving average is $1.78 and its two-hundred day simple moving average is $1.60. The firm has a market capitalization of $1.01 billion, a PE ratio of 151.15 and a beta of 0.42. The company has a current ratio of 3.16, a quick ratio of 2.39 and a debt-to-equity ratio of 0.46.</p>
<div class="lb-trans"><p>该公司的 50 日简单移动平均线为 1.78 美元，200 日简单移动平均线为 1.60 美元。该公司的市值为 10.1 亿美元，市盈率为 151.15，贝塔值为 0.42。公司当前比率为 3.16，速动比率为 2.39，债务与股本比率为 0.46。</p>
</div><h2>About Pharming Group</h2>
<div class="lb-trans"><h2>关于 Pharming Group</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Pharming Group NV is a Netherlands-based biopharmaceutical company specializing in the development and commercialization of protein replacement therapies for rare diseases. Founded in 1988 and headquartered in Leiden, the company leverages transgenic technology to produce recombinant proteins, with its flagship product RUCONEST (recombinant C1 esterase inhibitor) indicated for the treatment of acute hereditary angioedema (HAE) attacks. RUCONEST is approved and marketed in the United States, Europe and several other territories through partnerships with leading specialty pharmaceutical companies.</p>
<div class="lb-trans"><p>Pharming Group NV 是一家总部位于荷兰的生物制药公司，专注于为罕见疾病开发和商业化蛋白质替代疗法。公司成立于 1988 年，总部位于莱顿，利用转基因技术生产重组蛋白，其旗舰产品 RUCONEST（重组 C1 酯酶抑制剂）用于治疗急性遗传性血管性水肿（HAE）发作。RUCONEST 已在美国、欧洲及其他多个地区获得批准并通过与领先的专业制药公司合作进行市场推广。</p>
</div><p>Beyond RUCONEST, Pharming maintains a diversified pipeline targeting unmet needs in rare and ultra-rare disorders.</p>
<div class="lb-trans"><p>除了 RUCONEST，Pharming 还保持着多样化的产品线，针对罕见和超罕见疾病的未满足需求。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Pharming Group</li>
<li>BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align</li>
<li>Your name isn't on our protected list yet</li>
<li>Silver paying 20% dividend. Plus 68% share gains</li>
<li>“Fed Proof” Your Bank Account with THESE 4 Simple Steps</li>
<li>What a Former CIA Agent Knows About the Coming Collapse</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Pharming Group</li>
<li>BNZI 在 Zacks 买入评级中脱颖而出。盈利势头和分析师升级一致</li>
<li>你的名字尚未在我们的保护名单上</li>
<li>银银支付 20% 股息。此外，股价上涨 68%</li>
<li>用这 4 个简单步骤 “防止美联储影响” 你的银行账户</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Pharming Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Pharming Group 吗？</h2>
</div><p>Before you consider Pharming Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Pharming Group 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pharming Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Pharming Group 并不在名单上。</p>
</div><p>While Pharming Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Pharming Group 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Pharming Group (OTCMKTS:PHGUF) 股价跳空下跌 - 以下是发生的情况